CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $33 | -99.9% | 5,789 | -7.6% | 0.00% | – |
Q3 2022 | $41,000 | – | 6,262 | +4248.6% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 144 | -98.3% | 0.00% | – |
Q1 2022 | $28,000 | -60.0% | 8,468 | -51.0% | 0.00% | – |
Q3 2021 | $70,000 | -2.8% | 17,288 | 0.0% | 0.00% | – |
Q2 2021 | $72,000 | +30.9% | 17,288 | +55.6% | 0.00% | – |
Q1 2021 | $55,000 | +358.3% | 11,112 | +810.8% | 0.00% | – |
Q2 2020 | $12,000 | -29.4% | 1,220 | -37.5% | 0.00% | – |
Q1 2020 | $17,000 | -87.3% | 1,951 | -86.6% | 0.00% | – |
Q4 2019 | $134,000 | +252.6% | 14,605 | +122.7% | 0.00% | – |
Q3 2019 | $38,000 | +171.4% | 6,557 | +442.8% | 0.00% | – |
Q2 2019 | $14,000 | – | 1,208 | +5652.4% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 21 | -79.2% | 0.00% | – |
Q3 2018 | $1,000 | -98.5% | 101 | -97.4% | 0.00% | – |
Q2 2018 | $65,000 | – | 3,865 | +21372.2% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 18 | -99.9% | 0.00% | -100.0% |
Q3 2017 | $222,000 | +241.5% | 15,058 | +221.8% | 0.01% | +200.0% |
Q2 2017 | $65,000 | +170.8% | 4,680 | +219.9% | 0.00% | +200.0% |
Q1 2017 | $24,000 | -48.9% | 1,463 | -41.1% | 0.00% | -75.0% |
Q4 2015 | $47,000 | – | 2,485 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |